Sex differences in Attention Deficit Hyperactivity Disorder: Candidate genetic and endocrine mechanisms

Frontiers in Neuroendocrinology

Volumn 35, Issue 3, 2014, Pages 331-346

  Davies, William ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Autism; Basal ganglia; Imprinted gene; Mouse; Rat; Sex chromosome; Sry; Steroid sulfatase; Testosterone; Thalamus

Indexed keywords

ANDROGEN; SEX HORMONE; TESTOSTERONE;

ATTENTION DEFICIT DISORDER; COMORBIDITY; DISEASE COURSE; DISEASE PREDISPOSITION; EPIGENETICS; GENE DOSAGE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOME IMPRINTING; HORMONE ACTION; HUMAN; MONOAMINERGIC SYSTEM; NEUROBIOLOGY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SRY GENE; X CHROMOSOME; Y CHROMOSOME; ANIMAL; BEHAVIOR; ENDOCRINE SYSTEM; GENETIC PREDISPOSITION; GENETICS; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR; ENDOCRINE SYSTEM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS; SEX CHARACTERISTICS;

EID: 84903753690     PISSN: 00913022     EISSN: 10956808     Source Type: Journal    
DOI: 10.1016/j.yfrne.2014.03.003     Document Type: Review

References (262)

1. Aksglaede L., Skakkebaek N.E., Juul A. Abnormal sex chromosome constitution and longitudinal growth: serum levels of insulin-like growth factor (IGF)-I, IGF binding protein-3, luteinizing hormone, and testosterone in 109 males with 47,XXY, 47,XYY, or sex-determining region of the Y chromosome (SRY)-positive 46,XX karyotypes. J. Clin. Endocrinol. Metab. 2008, 93:169-176. 10.1210/jc.2007-1426.
2. Akutagava-Martins G.C., Salatino-Oliveira A., Kieling C.C., Rohde L.A., Hutz M.H. Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. Expert Rev. Neurother. 2013, 13:435-445. 10.1586/ern.13.30.
3. Arnold A.P. Sex chromosomes and brain gender. Nat. Rev. Neurosci. 2004, 5:701-708. 10.1038/nrn1494.
4. Arnold A.P., Chen X. What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues?. Front. Neuroendocrinol. 2009, 30:1-9. 10.1016/j.yfrne.2008.11.001.
5. Arnsten A.F. Catecholamine influences on dorsolateral prefrontal cortical networks. Biol. Psychiatry 2011, 69:89-99. 10.1016/j.biopsych.2011.01.027.
6. Attermann J., Obel C., Bilenberg N., Nordenbaek C.M., Skytthe A., Olsen J. Traits of ADHD and autism in girls with a twin brother: a Mendelian randomization study. Eur. Child Adolesc. Psychiatry 2012, 21:503-509. 10.1007/s00787-012-0287-4.
7. Aubele T., Kritzer M.F. Gonadectomy and hormone replacement affects in vivo basal extracellular dopamine levels in the prefrontal cortex but not motor cortex of adult male rats. Cereb. Cortex 2011, 21:222-232. 10.1093/cercor/bhq083.
8. Austad S.N. Why women live longer than men: sex differences in longevity. Gend. Med. 2006, 3:79-92.
9. Auyeung B., Ahluwalia J., Thomson L., Taylor K., Hackett G., O'Donnell K.J., Baron-Cohen S. Prenatal versus postnatal sex steroid hormone effects on autistic traits in children at 18 to 24 months of age. Mol. Autism. 2012, 3:17. 10.1186/2040-2392-3-17.
10. Auyeung B., Knickmeyer R., Ashwin E., Taylor K., Hackett G., Baron-Cohen S. Effects of fetal testosterone on visuospatial ability. Arch. Sex. Behav. 2012, 41:571-581. 10.1007/s10508-011-9864-8.
11. Avdjieva-Tzavella D.M., Todorov T.P., Todorova A.P., Kirov A.V., Hadjidekova S.P., Rukova B.B., Litvinenko I.O., Hristova-Naydenova D.N., Tincheva R.S., Toncheva D.I. Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism. Genet. Couns. 2012, 23:505-511.
12. Babinski D.E., Sibley M.H., Ross J.M., Pelham W.E. The effects of single versus mixed gender treatment for adolescent girls with ADHD. J. Clin. Child Adolesc. Psychol. 2013, 42:243-250. 10.1080/15374416.2012.756814.
13. Baeyens D., Roeyers H., Walle J.V. Subtypes of attention-deficit/hyperactivity disorder (ADHD): distinct or related disorders across measurement levels?. Child Psychiatry Hum. Dev. 2006, 36:403-417. 10.1007/s10578-006-0011-z.
14. Bahmanyar S., Sundstrom A., Kaijser M., von Knorring A.L., Kieler H. Pharmacological treatment and demographic characteristics of pediatric patients with Attention Deficit Hyperactivity Disorder, Sweden. Eur. Neuropsychopharmacol. 2013, 10.1016/j.euroneuro.2013.07.009.
15. Balint S., Czobor P., Komlosi S., Meszaros A., Simon V., Bitter I. Attention deficit hyperactivity disorder (ADHD): gender- and age-related differences in neurocognition. Psychol. Med. 2009, 39:1337-1345. 10.1017/S0033291708004236.
16. Banerjee T.D., Middleton F., Faraone S.V. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr. 2007, 96:1269-1274. 10.1111/j.1651-2227.2007.00430.x.
17. Bannbers E., Gingnell M., Engman J., Morell A., Comasco E., Kask K., Garavan H., Wikstrom J., Sundstrom Poromaa I. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition. J. Affect. Disord. 2012, 142:347-350. 10.1016/j.jad.2012.04.006.
18. Bao A.M., Swaab D.F. Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders. Front. Neuroendocrinol. 2011, 32:214-226. 10.1016/j.yfrne.2011.02.007.
19. Barker J.M., Torregrossa M.M., Arnold A.P., Taylor J.R. Dissociation of genetic and hormonal influences on sex differences in alcoholism-related behaviors. J. Neurosci. 2010, 30:9140-9144. 10.1523/JNEUROSCI.0548-10.2010.
20. Barkley R.A. ADHD: A Handbook for Diagnosis and Treatment 2006, Guildford Press. third ed.
21. Baron-Cohen S., Lombardo M.V., Auyeung B., Ashwin E., Chakrabarti B., Knickmeyer R. Why are autism spectrum conditions more prevalent in males?. PLoS Biol. 2011, 9:e1001081. 10.1371/journal.pbio.1001081.
22. Barry R.J., Clarke A.R., McCarthy R., Selikowitz M. Age and gender effects in EEG coherence: III. Girls with attention-deficit/hyperactivity disorder. Clin. Neurophysiol. 2006, 117:243-251. 10.1016/j.clinph.2005.09.026.
23. Berenbaum S.A., Bryk K.K., Nowak N., Quigley C.A., Moffat S. Fingers as a marker of prenatal androgen exposure. Endocrinology 2009, 150:5119-5124. 10.1210/en.2009-0774.
24. Berletch J.B., Yang F., Xu J., Carrel L., Disteche C.M. Genes that escape from X inactivation. Hum. Genet. 2011, 130:237-245. 10.1007/s00439-011-1011-z.
25. Biederman J., Mick E., Faraone S.V., Braaten E., Doyle A., Spencer T., Wilens T.E., Frazier E., Johnson M.A. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am. J. Psychiatry 2002, 159:36-42.
26. Biederman J., Kwon A., Aleardi M., Chouinard V.A., Marino T., Cole H., Mick E., Faraone S.V. Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. Am. J. Psychiatry 2005, 162:1083-1089. 10.1176/appi.ajp.162.6.1083.
27. Biederman J., Kim J.W., Doyle A.E., Mick E., Fagerness J., Smoller J.W., Faraone S.V. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:1511-1518. 10.1002/ajmg.b.30874.
28. Bishop D.V., Canning E., Elgar K., Morris E., Jacobs P.A., Skuse D.H. Distinctive patterns of memory function in subgroups of females with Turner syndrome: evidence for imprinted loci on the X-chromosome affecting neurodevelopment. Neuropsychologia 2000, 38:712-721.
29. Blanco P., Sargent C.A., Boucher C.A., Mitchell M., Affara N.A. Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain. Mamm. Genome 2000, 11:906-914. 10.1007/s003350010177.
30. Blasi F., Bacchelli E., Pesaresi G., Carone S., Bailey A.J., Maestrini E. Absence of coding mutations in the X-linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:220-221. 10.1002/ajmg.b.30287.
31. Bledsoe J., Semrud-Clikeman M., Pliszka S.R. A magnetic resonance imaging study of the cerebellar vermis in chronically treated and treatment-naive children with attention-deficit/hyperactivity disorder combined type. Biol. Psychiatry 2009, 65:620-624. 10.1016/j.biopsych.2008.11.030.
32. Bondy C.A. Turner syndrome 2008. Horm. Res. 2009, 71:52-56. 10.1159/000178039.
33. Bottos A., Rissone A., Bussolino F., Arese M. Neurexins and neuroligins: synapses look out of the nervous system. Cell. Mol. Life Sci. 2011, 68:2655-2666. 10.1007/s00018-011-0664-z.
34. Bradley C. The behavior of children receiving benzedrine. Am. J. Psychiatry 1937, 94:577-585.
35. Breedlove S.M. Minireview: organizational hypothesis: instances of the fingerpost. Endocrinology 2010, 151:4116-4122. 10.1210/en.2010-0041.
36. Brookes K., Xu X., Chen W., Zhou K., Neale B., Lowe N., et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol. Psychiatry 2006, 11:934-953. 10.1038/sj.mp.4001869.
37. Brookes K.J., Hawi Z., Kirley A., Barry E., Gill M., Kent L. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(8):1531-1535. 10.1002/ajmg.b.30873.
38. Brookes K.J., Hawi Z., Park J., Scott S., Gill M., Kent L. Polymorphisms of the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity disorder and influence brain tissue mRNA expression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:1417-1424. 10.1002/ajmg.b.31120.
39. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262:578-580.
40. Bucci D.J., Hopkins M.E., Nunez A.A., Breedlove S.M., Sisk C.L., Nigg J.T. Effects of sex hormones on associative learning in spontaneously hypertensive rats. Physiol. Behav. 2008, 93:651-657. 10.1016/j.physbeh.2007.11.005.
41. Cahill L. Why sex matters for neuroscience. Nat. Rev. Neurosci. 2006, 7:477-484. 10.1038/nrn1909.
42. Carlson C.L., Booth J.E., Shin M., Canu W.H. Parent-, teacher-, and self-rated motivational styles in ADHD subtypes. J. Learn Disabil. 2002, 35:104-113.
43. Carrel L., Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404. 10.1038/nature03479.
44. Castellanos F.X., Proal E. Large-scale brain systems in ADHD: beyond the prefrontal-striatal model. Trends Cogn. Sci. 2012, 16:17-26. 10.1016/j.tics.2011.11.007.
45. Catala-Lopez F., Peiro S., Ridao M., Sanfelix-Gimeno G., Genova-Maleras R., Catala M.A. Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies. BMC Psychiatry 2012, 12:168. 10.1186/1471-244X-12-168.
46. Chelaru M.I., Yang P.B., Dafny N. Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD). Behav. Brain Res. 2012, 226:8-17. 10.1016/j.bbr.2011.08.027.
47. Chen X., Grisham W., Arnold A.P. X chromosome number causes sex differences in gene expression in adult mouse striatum. Eur. J. Neurosci. 2009, 29:768-776. 10.1111/j.1460-9568.2009.06610.x.
48. Chen X., Williams-Burris S.M., McClusky R., Ngun T.C., Ghahramani N., Barseghyan H., Reue K., Vilain E., Arnold A.P. The Sex Chromosome Trisomy mouse model of XXY and XYY: metabolism and motor performance. Biol. Sex Differ. 2013, 4:15. 10.1186/2042-6410-4-15.
49. Chura L.R., Lombardo M.V., Ashwin E., Auyeung B., Chakrabarti B., Bullmore E.T., Baron-Cohen S. Organizational effects of fetal testosterone on human corpus callosum size and asymmetry. Psychoneuroendocrinology 2010, 35:122-132. 10.1016/j.psyneuen.2009.09.009.
50. Colborn T. Neurodevelopment and endocrine disruption. Environ. Health Perspect. 2004, 112:944-949.
51. Cole W.R., Mostofsky S.H., Larson J.C., Denckla M.B., Mahone E.M. Age-related changes in motor subtle signs among girls and boys with ADHD. Neurology 2008, 71:1514-1520. 10.1212/01.wnl.0000334275.57734.5f.
52. Comings D.E., Chen C., Wu S., Muhleman D. Association of the androgen receptor gene (AR) with ADHD and conduct disorder. NeuroReport 1999, 10:1589-1592.
53. Compagnone N.A., Salido E., Shapiro L.J., Mellon S.H. Expression of steroid sulfatase during embryogenesis. Endocrinology 1997, 138:4768-4773.
54. Cornforth C., Sonuga-Barke E., Coghill D. Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients. Curr. Pharm. Des. 2010, 16:2424-2433.
55. Cortese S. The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): what every clinician should know. Eur. J. Paediatr. Neurol. 2012, 16(5):422-433. 10.1016/j.ejpn.2012.01.009.
56. Cuevas-Covarrubias S.A., Juarez-Oropeza M.A., Miranda-Zamora R., Diaz-Zagoya J.C. Comparative analysis of human steroid sulfatase activity in prepubertal and postpubertal males and females. Biochem. Mol. Biol. Int. 1993, 30:691-695.
57. Czech D.P., Lee J., Sim H., Parish C.L., Vilain E., Harley V.R. The human testis-determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism. J. Neurochem. 2012, 122:260-271. 10.1111/j.1471-4159.2012.07782.x.
58. Dalsgaard S. Attention-deficit/hyperactivity disorder (ADHD). Eur. Child Adolesc. Psychiatry 2013, 22. S43-8. 10.1007/s00787-012-0360-z.
59. Das Bhowmik A., Das M., Sinha S., Mukhopadhyay K. Analysis of monoamine oxidase A promoter polymorphism in mentally retarded individuals. Psychiatry Genet. 2007, 17:5. 10.1097/YPG.0b013e328011189b.
60. Davies W. Genomic imprinting on the X chromosome: implications for brain and behavioral phenotypes. Ann. N. Y. Acad. Sci. 2010, 1204:E14-E19. 10.1111/j.1749-6632.2010.05567.x.
61. Davies W. Does steroid sulfatase deficiency influence postpartum psychosis risk?. Trends Mol. Med. 2012, 18:256-262. 10.1016/j.molmed.2012.03.001.
62. Davies W. Using mouse models to investigate sex-linked genetic effects on brain, behaviour and vulnerability to neuropsychiatric disorders. Brain Res. Bull. 2013, 92:12-20. 10.1016/j.brainresbull.2011.06.018.
63. Davies W., Wilkinson L.S. It is not all hormones: alternative explanations for sexual differentiation of the brain. Brain Res. 2006, 1126:36-45. 10.1016/j.brainres.2006.09.105.
64. Davies W., Isles A., Smith R., Karunadasa D., Burrmann D., Humby T., et al. Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice. Nat. Genet. 2005, 37:625-629. 10.1038/ng1577.
65. Davies W., Isles A.R., Burgoyne P.S., Wilkinson L.S. X-linked imprinting: effects on brain and behaviour. BioEssays 2006, 28:35-44. 10.1002/bies.20341.
66. Davies W., Humby T., Isles A.R., Burgoyne P.S., Wilkinson L.S. X-monosomy effects on visuospatial attention in mice: a candidate gene and implications for Turner syndrome and attention deficit hyperactivity disorder. Biol. Psychiatry 2007, 61:1351-1360. 10.1016/j.biopsych.2006.08.011.
67. Davies W., Humby T., Kong W., Otter T., Burgoyne P.S., Wilkinson L.S. Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention. Biol. Psychiatry 2009, 66:360-367. 10.1016/j.biopsych.2009.01.001.
68. de Bruin E.I., Verheij F., Wiegman T., Ferdinand R.F. Differences in finger length ratio between males with autism, pervasive developmental disorder-not otherwise specified, ADHD, and anxiety disorders. Dev. Med. Child Neurol. 2006, 48:962-965. 10.1017/S0012162206002118.
69. De La Fuente A., Xia S., Branch C., Li X. A review of attention-deficit/hyperactivity disorder from the perspective of brain networks. Front Hum. Neurosci. 2013, 7:192. 10.3389/fnhum.2013.00192.
70. Del Campo N., Chamberlain S.R., Sahakian B.J., Robbins T.W. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol. Psychiatry 2011, 69:145-157. 10.1016/j.biopsych.2011.02.036.
71. Dempster E.L., Mill J., Craig I.W., Collier D.A. The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression. BMC Med. Genet. 2006, 7:10. 10.1186/1471-2350-7-10.
72. Dennis E.L., Thompson P.M. Mapping connectivity in the developing brain. Int. J. Dev. Neurosci. 2013, 31:525-542. 10.1016/j.ijdevneu.2013.05.007.
73. Derks E.M., Hudziak J.J., Boomsma D.I. Why more boys than girls with ADHD receive treatment: a study of Dutch twins. Twin. Res. Hum. Genet. 2007, 10:765-770. 10.1375/twin.10.5.765.
74. DeVeale B., van der Kooy D., Babak T. Critical evaluation of imprinted gene expression by RNA-Seq: a new perspective. PLoS Genet. 2012, 8:e1002600. 10.1371/journal.pgen.1002600.
75. Dewing P., Shi T., Horvath S., Vilain E. Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation. Brain Res. Mol. Brain Res. 2003, 118:82-90.
76. Dewing P., Chiang C.W., Sinchak K., Sim H., Fernagut P.O., Kelly S., Chesselet M.F., Micevych P.E., Albrecht K.H., Harley V.R., Vilain E. Direct regulation of adult brain function by the male-specific factor SRY. Curr. Biol. 2006, 16:415-420. 10.1016/j.cub.2006.01.017.
77. Diamond A. Attention-deficit disorder (attention-deficit/hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity). Dev. Psychopathol. 2005, 17:807-825. 10.1017/S0954579405050388.
78. Dickey C., Toot J., Terwilliger M., Payne R., Turner M., Ely D. The SHR Y chromosome increases cardiovascular, endocrine, and behavioral responses to stress compared to the WKY Y chromosome. Physiol. Behav. 2012, 106:101-108. 10.1016/j.physbeh.2012.01.009.
79. Doherty M.J., Glass I.A., Bennett C.L., Cotter P.D., Watson N.F., Mitchell A.L., Bird T.D., Farrell D.F. An Xp; Yq translocation causing a novel contiguous gene syndrome in brothers with generalized epilepsy, ichthyosis, and attention deficits. Epilepsia 2003, 44:1529-1535.
80. Dupont C., Gribnau J. Different flavors of X-chromosome inactivation in mammals. Curr. Opin. Cell Biol. 2013, 25:314-321. 10.1016/j.ceb.2013.03.001.
81. Durand C.M., Kappeler C., Betancur C., Delorme R., Quach H., Goubran-Botros H., et al. Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:67-70. 10.1002/ajmg.b.30229.
82. El-Eshmawy M.M., Yahia S., El-Dahtory F.A., Hamed S., El Hadidy el H.M., Ragab M. Hidden Y chromosome mosaicism in 48 Egyptian patients with Turner's syndrome. Genet. Res. Int. 2013, 463529. 10.1155/2013/463529.
83. Eme R.F. Sex differences in child-onset, life-course-persistent conduct disorder. a review of biological influences. Clin. Psychol. Rev. 2007, 27:607-627. 10.1016/j.cpr.2007.02.001.
84. Faulk C., Barks A., Liu K., Goodrich J.M., Dolinoy D.C. Early-life lead exposure results in dose- and sex-specific effects on weight and epigenetic gene regulation in weanling mice. Epigenomics 2013, 5:487-500. 10.2217/epi.13.49.
85. Fernandes N.F., Janniger C.K., Schwartz R.A. X-linked ichthyosis: an oculocutaneous genodermatosis. J. Am. Acad. Dermatol. 2010, 62:480-485. 10.1016/j.jaad.2009.04.028.
86. Fernandez-Guasti A., Kruijver F.P., Fodor M., Swaab D.F. Sex differences in the distribution of androgen receptors in the human hypothalamus. J. Comp. Neurol. 2000, 425:422-435. 10.1002/1096-9861.
87. Fletcher P.J., Soko A.D., Higgins G.A. Impulsive action in the 5-choice serial reaction time test in 5-HT(2)c receptor null mutant mice. Psychopharmacology 2013, 226:561-570. 10.1007/s00213-012-2929-0.
88. Franke B., Neale B.M., Faraone S.V. Genome-wide association studies in ADHD. Hum. Genet. 2009, 126:13-50. 10.1007/s00439-009-0663-4.
89. Freriks K., Timmers H.J., Netea-Maier R.T., Beerendonk C.C., Otten B.J., van Alfen-van der Velden J.A. Buccal cell FISH and blood PCR-Y detect high rates of X chromosomal mosaicism and Y chromosomal derivatives in patients with Turner syndrome. Eur. J. Med. Genet. 2013, 56:497-501. 10.1016/j.ejmg.2013.07.008.
90. Frodl T., Skokauskas N. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatry Scand. 2012, 125:114-126. 10.1111/j.1600-0447.2011.01786.x.
91. Garbe E., Mikolajczyk R.T., Banaschewski T., Petermann U., Petermann F., Kraut A.A., Langner I. Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study. J. Child Adolesc. Psychopharmacol. 2012, 22:452-458. 10.1089/cap.2012.0022.
92. Gaub M., Carlson C.L. Gender differences in ADHD: a meta-analysis and critical review. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36:1036-1045. 10.1097/00004583-199708000-00011.
93. Genro J.P., Kieling C., Rohde L.A., Hutz M.H. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Expert Rev. Neurother. 2010, 10:587-601. 10.1586/ern.10.17.
94. Ghanizadeh A. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender. J. Child Neurol. 2009, 24:679-684. 10.1177/0883073808331086.
95. Gibb S.J., Fergusson D.M., Horwood L.J. Gender differences in educational achievement to age 25. Aust. J. Educ. 2008, 52:63-80.
96. Giedd J.N., Rapoport J.L. Structural MRI of pediatric brain development: what have we learned and where are we going?. Neuron 2010, 67:728-734. 10.1016/j.neuron.2010.08.040.
97. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Hum. Genet. 2009, 126:51-90. 10.1007/s00439-009-0694-x.
98. Gregg C., Zhang J., Butler J.E., Haig D., Dulac C. Sex-specific parent-of-origin allelic expression in the mouse brain. Science 2010, 329:682-685. 10.1126/science.1190831.
99. Gregg C., Zhang J., Weissbourd B., Luo S., Schroth G.P., Haig D., Dulac C. High-resolution analysis of parent-of-origin allelic expression in the mouse brain. Science 2010, 329:643-648. 10.1126/science.1190830.
100. Hasson R., Fine J.G. Gender differences among children with ADHD on continuous performance tests: a meta-analytic review. J. Atten. Disord. 2012, 16:190-198. 10.1177/1087054711427398.
101. Hermens D.F., Kohn M.R., Clarke S.D., Gordon E., Williams L.M. Sex differences in adolescent ADHD: findings from concurrent EEG and EDA. Clin. Neurophysiol. 2005, 116:1455-1463. 10.1016/j.clinph.2005.02.012.
102. Hines M. Early androgen influences on human neural and behavioural development. Early Hum. Dev. 2008, 84:805-807. 10.1016/j.earlhumdev.2008.09.006.
103. Hinshaw S.P., Owens E.B., Sami N., Fargeon S. Prospective follow-up of girls with attention-deficit/hyperactivity disorder into adolescence: evidence for continuing cross-domain impairment. J. Consult. Clin. Psychol. 2006, 74:489-499. 10.1037/0022-006X.74.3.489.
104. Holden C. Sex and the suffering brain. Science 2005, 308:1574. 10.1126/science.308.5728.1574.
105. Homberg J.R. Serotonin and decision making processes. Neurosci. Biobehav. Rev. 2012, 36:218-236. 10.1016/j.neubiorev.2011.06.001.
106. Humby T., Wilkinson L.S. Assaying dissociable elements of behavioural inhibition and impulsivity: translational utility of animal models. Curr. Opin. Pharmacol. 2011, 11:534-539. 10.1016/j.coph.2011.06.006.
107. Humby T., Laird F.M., Davies W., Wilkinson L.S. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur. J. Neurosci. 1999, 11:2813-2823. DOI:ejn701.
108. Humby T., Eddy J.B., Good M.A., Reichelt A.C., Wilkinson L.S. A novel translational assay of response inhibition and impulsivity: effects of prefrontal cortex lesions, drugs used in ADHD, and serotonin 2C receptor antagonism. Neuropsychopharmacology 2013, 38:2150-2159. 10.1038/npp.2013.112.
109. Isles A.R., Humby T., Wilkinson L.S. Measuring impulsivity in mice using a novel operant delayed reinforcement task: effects of behavioural manipulations and d-amphetamine. Psychopharmacology 2003, 170:376-382. 10.1007/s00213-003-1551-6.
110. Ivanov I., Bansal R., Hao X., Zhu H., Kellendonk C., Miller L., Sanchez-Pena J., Miller A.M., Chakravarty M.M., Klahr K., Durkin K., Greenhill L.L., Peterson B.S. Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder. Am. J. Psychiatry 2010, 167:397-408. 10.1176/appi.ajp.2009.09030398.
111. Jacob H.J., Lazar J., Dwinell M.R., Moreno C., Geurts A.M. Gene targeting in the rat: advances and opportunities. Trends Genet. 2010, 26:510-518. 10.1016/j.tig.2010.08.006.
112. Jensen J.B., Garfinkel B.D. Neuroendocrine aspects of attention deficit hyperactivity disorder. Endocrinol. Metab. Clin. North Am. 1988, 17:111-129.
113. Kebir O., Tabbane K., Sengupta S., Joober R. Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J. Psychiatry Neurosci. 2009, 34:88-101.
114. Kent L., Emerton J., Bhadravathi V., Weisblatt E., Pasco G., Willatt L.R., McMahon R., Yates J.R. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J. Med. Genet. 2008, 45:519-524. 10.1136/jmg.2008.057729.
115. King J.A., Barkley R.A., Delville Y., Ferris C.F. Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD. Behav. Brain Res. 2000, 107:35-43.
116. Kittles R.A., Long J.C., Bergen A.W., Eggert M., Virkkunen M., Linnoila M., Goldman D. Cladistic association analysis of Y chromosome effects on alcohol dependence and related personality traits. Proc. Natl. Acad. Sci. USA 1999, 96:4204-4209.
117. Kooij J.J., Huss M., Asherson P., Akehurst R., Beusterien K., French A., Sasane R., Hodgkins P. Distinguishing comorbidity and successful management of adult ADHD. J. Atten. Disord. 2012, 16:3S-19S. 10.1177/1087054711435361.
118. Kopsida E., Stergiakouli E., Lynn P.M., Wilkinson L.S., Davies W. The role of the Y chromosome in brain function. Open Neuroendocrinol. J. 2009, 2:20-30. 10.2174/1876528900902010020.
119. Kopsida E., Mikaelsson M.A., Davies W. The role of imprinted genes in mediating susceptibility to neuropsychiatric disorders. Horm. Behav. 2011, 59:375-382. 10.1016/j.yhbeh.2010.04.005.
120. Kopsida E., Lynn P.M., Humby T., Wilkinson L.S., Davies W. Dissociable effects of sry and sex chromosome complement on activity, feeding and anxiety-related behaviours in mice. PLoS ONE 2013, 8:e73699. 10.1371/journal.pone.0073699.
121. Kriz L., Bicikova M., Hill M., Hampl R. Steroid sulfatase and sulfuryl transferase activity in monkey brain tissue. Steroids 2005, 70:960-969. 10.1016/j.steroids.2005.07.005.
122. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 2004, 74:552-557. 10.1086/382137.
123. Lee J., Harley V.R. The male fight-flight response: a result of SRY regulation of catecholamines?. BioEssays 2012, 34:454-457. 10.1002/bies.201100159.
124. Lee M.S., Yang J.W., Ko Y.H., Han C., Kim S.H., Lee M.S., Joe S.H., Jung I.K. Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder. Child Psychiatry Hum. Dev. 2008, 39:201-209. 10.1007/s10578-007-0081-6.
125. Lee S.H., Ripke S., Neale B.M., Faraone S.V., Purcell S.M., Perlis R.H., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 2013, 45:984-994. 10.1038/ng.2711.
126. Leibson C.L., Katusic S.K., Barbaresi W.J., Ransom J., O'Brien P.C. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 2001, 285:60-66. DOI: joc01336.
127. Lemiere J., Boets B., Danckaerts M. No association between the 2D:4D fetal testosterone marker and multidimensional attentional abilities in children with ADHD. Dev. Med. Child Neurol. 2010, 52:e202-e208. 10.1111/j.1469-8749.2010.03684.x.
128. Lepage J.F., Hong D.S., Mazaika P.K., Raman M., Sheau K., Marzelli M.J., Hallmayer J., Reiss A.L. Genomic imprinting effects of the X chromosome on brain morphology. J. Neurosci. 2013, 33:8567-8574. 10.1523/JNEUROSCI.5810-12.2013.
129. Lewis C.M., Knight J. Introduction to genetic association studies. Cold Spring Harb. Protoc. 2012, 2012:297-306. 10.1101/pdb.top068163.
130. Li J.S., Huang Y.C. Early androgen treatment influences the pattern and amount of locomotion activity differently and sexually differentially in an animal model of ADHD. Behav. Brain Res. 2006, 175:176-182. 10.1016/j.bbr.2006.08.020.
131. Li J., Wang Y., Zhou R., Wang B., Zhang H., Yang L., Faraone S.V. Association of attention-deficit/hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects. Neurosci. Lett. 2006, 401:6-9. 10.1016/j.neulet.2006.02.053.
132. Li J., Wang Y., Zhou R., Zhang H., Yang L., Wang B., Faraone S.V. Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects. Neurosci. Lett. 2006, 407:107-111. 10.1016/j.neulet.2006.08.022.
133. Lichanska A.M., Waters M.J. How growth hormone controls growth, obesity and sexual dimorphism. Trends Genet. 2008, 24:41-47. 10.1016/j.tig.2007.10.006.
134. Linares L.O., Martinez-Martin N., Castellanos F.X. Stimulant and atypical antipsychotic medications for children placed in foster homes. PLoS ONE 2013, 8:e54152. 10.1371/journal.pone.0054152.
135. Lipszyc J., Schachar R. Inhibitory control and psychopathology: a meta-analysis of studies using the stop signal task. J. Int. Neuropsychol. Soc. 2010, 16:1064-1076. 10.1017/S1355617710000895.
136. Lombardo M.V., Ashwin E., Auyeung B., Chakrabarti B., Lai M.C., Taylor K., Hackett G., Bullmore E.T., Baron-Cohen S. Fetal programming effects of testosterone on the reward system and behavioral approach tendencies in humans. Biol. Psychiatry 2012, 72:839-847. 10.1016/j.biopsych.2012.05.027.
137. Lonardo F., Parenti G., Luquetti D.V., Annunziata I., Della Monica M., Perone L., De Gregori M., Zuffardi O., Brunetti-Pierri N., Andria G., Scarano G. Contiguous gene syndrome due to an interstitial deletion in Xp22.3 in a boy with ichthyosis, chondrodysplasia punctata, mental retardation and ADHD. Eur. J. Med. Genet. 2007, 50:301-308. 10.1016/j.ejmg.2007.04.005.
138. Lynn, P.M., 2010. Analysis of sex chromosome effects on behaviour. Ph.D thesis, Cardiff University, UK.
139. Lynn P.M., Davies W. The 39, XO mouse as a model for the neurobiology of Turner syndrome and sex-biased neuropsychiatric disorders. Behav. Brain Res. 2007, 179:173-182. 10.1016/j.bbr.2007.02.013.
140. Maayan R., Yoran-Hegesh R., Strous R., Nechmad A., Averbuch E., Weizman A., Spivak B. Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder. Neuropsychobiology 2003, 48:111-115.
141. Mahadevaiah S.K., Evans E.P., Burgoyne P.S. An analysis of meiotic impairment and of sex chromosome associations throughout meiosis in XYY mice. Cytogenet. Cell Genet. 2000, 89:29-37.
142. Mar A.C., Horner A.E., Nilsson S.R., Alsio J., Kent B.A., Kim C.H., Holmes A., Saksida L.M., Bussey T.J. The touchscreen operant platform for assessing executive function in rats and mice. Nat. Protoc. 2013, 8:1985-2005. 10.1038/nprot.2013.123.
143. Marchant B.K., Reimherr F.W., Halls C., Williams E.D., Strong R.E., Kondo D., Soni P., Robison R.J. Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine. Atten. Defic. Hyperact. Disord. 2011, 3:237-244. 10.1007/s12402-011-0054-2.
144. Martel M.M. Conscientiousness as a mediator of the association between masculinized finger-length ratios and attention-deficit/hyperactivity disorder (ADHD). J. Child Psychol. Psychiatry 2009, 50:790-798. 10.1111/j.1469-7610.2009.02065.x.
145. Mayer A., Lahr G., Swaab D.F., Pilgrim C., Reisert I. The Y-chromosomal genes SRY and ZFY are transcribed in adult human brain. Neurogenetics 1998, 1:281-288.
146. Mayer A., Mosler G., Just W., Pilgrim C., Reisert I. Developmental profile of Sry transcripts in mouse brain. Neurogenetics 2000, 3:25-30.
147. McCarthy M.M. Sexual differentiation of the brain in man and animals: of relevance to Klinefelter syndrome?. Am. J. Med. Genet. C 2013, 163C:3-15. 10.1002/ajmg.c.31351.
148. Mickey B.J., Sanford B.J., Love T.M., Shen P.H., Hodgkinson C.A., Stohler C.S., Goldman D., Zubieta J.K. Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans. J. Neurosci. 2012, 32:9344-9350. 10.1523/JNEUROSCI.1260-12.2012.
149. Mikami A.Y., Cox D.J., Davis M.T., Wilson H.K., Merkel R.L., Burket R. Sex differences in effectiveness of extended-release stimulant medication among adolescents with attention-deficit/hyperactivity disorder. J. Clin. Psychol. Med. Settings 2009, 16:233-242. 10.1007/s10880-009-9165-8.
150. Milsted A., Serova L., Sabban E.L., Dunphy G., Turner M.E., Ely D.L. Regulation of tyrosine hydroxylase gene transcription by Sry. Neurosci. Lett. 2004, 369:203-207. 10.1016/j.neulet.2004.07.052.
151. Modesto-Lowe V., Meyer A., Soovajian V. A clinican's guide to adult attention-deficit hyperactivity disorder. Conn. Med. 2012, 76:517-523.
152. Mohandas T., Sparkes R.S., Hellkuhl B., Grzeschik K.H., Shapiro L.J. Expression of an X-linked gene from an inactive human X chromosome in mouse-human hybrid cells: further evidence for the noninactivation of the steroid sulfatase locus in man. Proc. Natl. Acad. Sci. USA 1980, 77:6759-6763.
153. Morishita H., Yagi T. Protocadherin family: diversity, structure, and function. Curr. Opin. Cell Biol. 2007, 19:584-592. 10.1016/j.ceb.2007.09.006.
154. Mueller S.C., Ng P., Sinaii N., Leschek E.W., Green-Golan L., VanRyzin C., Ernst M., Merke D.P. Psychiatric characterization of children with genetic causes of hyperandrogenism. Eur. J. Endocrinol. 2010, 163:801-810. 10.1530/EJE-10-0693.
155. Mueller S.C., Merke D.P., Leschek E.W., Fromm S., VanRyzin C., Ernst M. Increased medial temporal lobe and striatal grey-matter volume in a rare disorder of androgen excess: a voxel-based morphometry (VBM) study. Int. J. Neuropsychopharmacol. 2011, 14:445-457. 10.1017/S1461145710001136.
156. Mulligan A., Gill M., Fitzgerald M. A case of ADHD and a major Y chromosome abnormality. J. Atten. Disord. 2008, 12:103-105. 10.1177/1087054707311220.
157. Nijhuis-van der Sanden M.W., Eling P.A., Otten B.J. A review of neuropsychological and motor studies in Turner Syndrome. Neurosci. Biobehav. Rev. 2003, 27:329-338.
158. Nussbaum N.L. ADHD and female specific concerns: a review of the literature and clinical implications. J. Atten. Disord. 2012, 16:87-100. 10.1177/1087054711416909.
159. Nyman E.S., Loukola A., Varilo T., Taanila A., Hurtig T., Moilanen I., Loo S., McGough J.J., Jarvelin M.R., Smalley S.L., Nelson S.F., Peltonen L. Sex-specific influence of DRD2 on ADHD-type temperament in a large population-based birth cohort. Psychiatry Genet. 2012, 22:197-201. 10.1097/YPG.0b013e32834c0cc8.
160. Nymberg C., Jia T., Lubbe S., Ruggeri B., Desrivieres S., Barker G., et al. Neural mechanisms of attention-deficit/hyperactivity disorder symptoms are stratified by MAOA genotype. Biol. Psychiatry 2013, 10.1016/j.biopsych.2013.03.027.
161. Oades R.D. Role of the serotonin system in ADHD: treatment implications. Expert Rev. Neurother. 2007, 7:1357-1374. 10.1586/14737175.7.10.1357.
162. Oades R.D. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog. Brain Res. 2008, 172:543-565. 10.1016/S0079-6123(08)00926-6.
163. O'Brien J.W., Dowell L.R., Mostofsky S.H., Denckla M.B., Mahone E.M. Neuropsychological profile of executive function in girls with attention-deficit/hyperactivity disorder. Arch. Clin. Neuropsychol. 2010, 25:656-670. 10.1093/arclin/acq050.
164. Pampanos A., Volaki K., Kanavakis E., Papandreou O., Youroukos S., Thomaidis L., Karkelis S., Tzetis M., Kitsiou-Tzeli S. A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. Genet. Test Mol. Biomarkers 2009, 13:611-615. 10.1089/gtmb.2009.0005.
165. Pastor P.N., Reuben C.A. Attention deficit disorder and learning disability: United States, 1997-98. Vital Health Stat. 2002, 10:1-12.
166. Pennanen L., van der Hart M., Yu L., Tecott L.H. Impact of serotonin (5-HT)2C receptors on executive control processes. Neuropsychopharmacology 2013, 38:957-967. 10.1038/npp.2012.258.
167. Perlov E., Philipsen A., Matthies S., Drieling T., Maier S., Bubl E., Hesslinger B., Buechert M., Henning J., Ebert D., Tebartz Van Elst L. Spectroscopic findings in attention-deficit/hyperactivity disorder: review and meta-analysis. World J. Biol. Psychiatry 2009, 10:355-365. 10.1080/15622970802176032.
168. Perumal A.S., Robins E. Regional and subcellular distribution of aryl-and steroid sulfatases in brain. Brain Res. 1973, 59:349-358.
169. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry 2007, 164:942-948. 10.1176/appi.ajp.164.6.942.
170. Preston B.T., Stevenson I.R., Lincoln G.A., Monfort S.L., Pilkington J.G., Wilson K. Testes size, testosterone production and reproductive behaviour in a natural mammalian mating system. J. Anim. Ecol. 2012, 81:296-305. 10.1111/j.1365-2656.2011.01907.x.
171. Prot J., Laska M. The linkage between Duchenne-type progressive muscular dystrophy and color blindness. Pol. Med. J. 1970, 9:1207-1211.
172. Purper-Ouakil D., Ramoz N., Lepagnol-Bestel A.M., Gorwood P., Simonneau M. Neurobiology of attention deficit/hyperactivity disorder. Pediatr. Res. 2011, 69:69R-76R. 10.1203/PDR.0b013e318212b40f.
173. Purves-Tyson T.D., Handelsman D.J., Double K.L., Owens S.J., Bustamante S., Weickert C.S. Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra. BMC Neurosci. 2012, 13:95. 10.1186/1471-2202-13-95.
174. Quintero A.I., Beaton E.A., Harvey D.J., Ross J.L., Simon T.J. Common and specific impairments in attention functioning in girls with chromosome 22q11.2 deletion, Fragile X or Turner syndromes. J. Neurodev. Disord. 2014, 6:5. 10.1186/1866-1955-6-5.
175. Raefski A.S., O'Neill M.J. Identification of a cluster of X-linked imprinted genes in mice. Nat. Genet. 2005, 37:620-624. 10.1038/ng1567.
176. Ratcliffe S.G., Read G., Pan H., Fear C., Lindenbaum R., Crossley J. Prenatal testosterone levels in XXY and XYY males. Horm. Res. 1994, 42:106-109.
177. Reed M.J., Purohit A., Woo L.W., Newman S.P., Potter B.V. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr. Rev. 2005, 26:171-202. 10.1210/er.2004-0003.
178. Rhodes M.E., Li P.K., Flood J.F., Johnson D.A. Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study. Brain Res. 1996, 733:284-286.
179. Rhodes M.E., Li P.K., Burke A.M., Johnson D.A. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res. 1997, 773:28-32.
180. Rizwan S., Manning J.T., Brabin B.J. Maternal smoking during pregnancy and possible effects of in utero testosterone: evidence from the 2D:4D finger length ratio. Early Hum. Dev. 2007, 83:87-90. 10.1016/j.earlhumdev.2006.05.005.
181. Robbins T.W., Roberts A.C. Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb. Cortex 2007, 17:151-160. 10.1093/cercor/bhm066.
182. Robinson E.S., Dalley J.W., Theobald D.E., Glennon J.C., Pezze M.A., Murphy E.R., Robbins T.W. Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology 2008, 33:2398-2406. 10.1038/sj.npp.1301636.
183. Rogol A.D. Sex steroids, growth hormone, leptin and the pubertal growth spurt. Endocr. Dev. 2010, 17:77-85. 10.1159/000262530.
184. Romero-Martinez A., Polderman T., Gonzalez-Bono E., Moya-Albiol L. Masculinization in parents of offspring with autism spectrum disorders could be involved in comorbid ADHD symptoms. J. Atten. Disord. 2013, 10.1177/1087054713482685.
185. Rommelse N.N., Altink M.E., Arias-Vasquez A., Buschgens C.J., Fliers E., Faraone S.V., Buitelaar J.K., Sergeant J.A., Oosterlaan J., Franke B. Differential association between MAOA, ADHD and neuropsychological functioning in boys and girls. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:1524-1530. 10.1002/ajmg.b.30845.
186. Rommelse N.N., Franke B., Geurts H.M., Hartman C.A., Buitelaar J.K. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur. Child Adolesc. Psychiatry 2010, 19:281-295. 10.1007/s00787-010-0092-x.
187. Ross J.L., Roeltgen D., Stefanatos G.A., Feuillan P., Kushner H., Bondy C., Cutler G.B. Androgen-responsive aspects of cognition in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 2003, 88:292-296.
188. Ross J.L., Stefanatos G.A., Kushner H., Bondy C., Nelson L., Zinn A., Roeltgen D. The effect of genetic differences and ovarian failure: intact cognitive function in adult women with premature ovarian failure versus turner syndrome. J. Clin. Endocrinol. Metab. 2004, 89:1817-1822.
189. Ross J.L., Zeger M.P., Kushner H., Zinn A.R., Roeltgen D.P. An extra X or Y chromosome: contrasting the cognitive and motor phenotypes in childhood in boys with 47, XYY syndrome or 47, XXY Klinefelter syndrome. Dev. Disabil. Res. Rev. 2009, 15:309-317. 10.1002/ddrr.85.
190. Rovet J. Turner syndrome: a review of genetic and hormonal influences on neuropsychological functioning. Child Neuropsychol. 2004, 10:262-279. 10.1080/09297040490909297.
191. Rucklidge J.J. Gender differences in attention-deficit/hyperactivity disorder. Psychiatry Clin. North Am. 2010, 33:357-373. 10.1016/j.psc.2010.01.006.
192. Russell H.F., Wallis D., Mazzocco M.M., Moshang T., Zackai E., Zinn A.R., Ross J.L., Muenke M. Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. J. Pediatr. Psychol. 2006, 31:945-955. 10.1093/jpepsy/jsj106.
193. Russell G., Rodgers L.R., Ukoumunne O.C., Ford T. Prevalence of parent-reported ASD and ADHD in the UK: findings from the millennium cohort study. J. Autism Dev. Disord. 2013, 10.1007/s10803-013-1849-0.
194. Ruud A., Arnesen P., Stray L.L., Vildalen S., Vesterhus P. Stimulant medication in 47, XYY syndrome: a report of two cases. Dev. Med. Child Neurol. 2005, 47:559-562.
195. Sagi L., Zuckerman-Levin N., Gawlik A., Ghizzoni L., Buyukgebiz A., Rakover Y., Bistritzer T., Admoni O., Vottero A., Baruch O., Fares F., Malecka-Tendera E., Hochberg Z. Clinical significance of the parental origin of the X chromosome in turner syndrome. J. Clin. Endocrinol. Metab. 2007, 92:846-852. 10.1210/jc.2006-0158.
196. Salum G.A., Sergeant J., Sonuga-Barke E., Vandekerckhove J., Gadelha A., Pan P.M., Moriyama T.S., Graeff-Martins A.S., de Alvarenga P.G., do Rosario M.C., Manfro G.G., Polanczyk G., Rohde L.A. Specificity of basic information processing and inhibitory control in attention deficit hyperactivity disorder. Psychol. Med. 2013, 1-15. 10.1017/S0033291713000639.
197. Sarter M., Paolone G. Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches. Behav. Neurosci. 2011, 125:825-835. 10.1037/a0026227.
198. Scerbo A.S., Kolko D.J. Salivary testosterone and cortisol in disruptive children: relationship to aggressive, hyperactive, and internalizing behaviors. J. Am. Acad. Child Adolesc. Psychiatry 1994, 33:1174-1184. 10.1097/00004583-199410000-00013.
199. Schweren L.J., de Zeeuw P., Durston S. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder. Eur. Neuropsychopharmacol. 2013, 23:1151-1164. 10.1016/j.euroneuro.2012.10.014.
200. Sciutto M.J., Nolfi C.J., Bluhm C. Effects of child gender and symptom type on referrals for ADHD by elementary school teachers. J. Emot. Behav. Disord. 2004, 12:247-253.
201. Seidman L.J., Valera E.M., Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol. Psychiatry 2005, 57:1263-1272. 10.1016/j.biopsych.2004.11.019.
202. Sengupta S.M., Grizenko N., Thakur G.A., Bellingham J., DeGuzman R., Robinson S., TerStepanian M., Poloskia A., Shaheen S.M., Fortier M.E., Choudhry Z., Joober R. Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype. J. Psychiatry Neurosci. 2012, 37:129-137. 10.1503/jpn.110073.
203. Serajee F.J., Mahbubul Huq A.H. Association of Y chromosome haplotypes with autism. J. Child Neurol. 2009, 24:1258-1261. 10.1177/0883073809333530.
204. Shah S.S., Ayub Q., Firasat S., Kaiser F., Mehdi S.Q. Y haplogroups and aggressive behavior in a Pakistani ethnic group. Aggress. Behav. 2009, 35:68-74. 10.1002/ab.20281.
205. Shaw P., Rabin C. New insights into attention-deficit/hyperactivity disorder using structural neuroimaging. Curr. Psychiatry Rep. 2009, 11:393-398.
206. Silk T.J., Vance A., Rinehart N., Bradshaw J.L., Cunnington R. Structural development of the basal ganglia in attention deficit hyperactivity disorder: a diffusion tensor imaging study. Psychiatry Res. 2009, 172:220-225. 10.1016/j.pscychresns.2008.07.003.
207. Simon V., Czobor P., Balint S., Meszaros A., Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br. J. Psychiatry 2009, 194:204-211. 10.1192/bjp.bp.107.048827.
208. Singh M.K., Chang K.D. The neural effects of psychotropic medications in children and adolescents. Child Adolesc. Psychiatr. Clin. N Am. 2012, 21:753-771. 10.1016/j.chc.2012.07.010.
209. Skuse D.H., James R.S., Bishop D.V., Coppin B., Dalton P., Aamodt-Leeper G., Bacarese-Hamilton M., Creswell C., McGurk R., Jacobs P.A. Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 1997, 387:705-708. 10.1038/42706.
210. Solis-Ortiz S., Corsi-Cabrera M. Sustained attention is favored by progesterone during early luteal phase and visuo-spatial memory by estrogens during ovulatory phase in young women. Psychoneuroendocrinology 2008, 33:989-998. 10.1016/j.psyneuen.2008.04.003.
211. Sonuga-Barke E.J., Coghill D., Markowitz J.S., Swanson J.M., Vandenberghe M., Hatch S.J. Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. J. Am. Acad. Child Adolesc. Psychiatry 2007, 46:701-710. 10.1097/chi.0b013e31804659f1.
212. Steckelbroeck S., Nassen A., Ugele B., Ludwig M., Watzka M., Reissinger A., Clusmann H., Lutjohann D., Siekmann L., Klingmuller D., Hans V.H. Steroid sulfatase (STS) expression in the human temporal lobe: enzyme activity, mRNA expression and immunohistochemistry study. J. Neurochem. 2004, 89:403-417. 10.1046/j.1471-4159.2004.02336.x.
213. Stergiakouli E., Langley K., Williams H., Walters J., Williams N.M., Suren S., Giegling I., Wilkinson L.S., Owen M.J., O'Donovan M.C., Rujescu D., Thapar A., Davies W. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder. Genes Brain Behav. 2011, 10:334-344. 10.1111/j.1601-183X.2010.00672.x.
214. Stergiakouli E., Hamshere M., Holmans P., Langley K., Zaharieva I., Hawi Z., Kent L., Gill M., Williams N., Owen M.J., O'Donovan M., Thapar A. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am. J. Psychiatry 2012, 169:186-194.
215. Stevenson J.C., Everson P.M., Williams D.C., Hipskind G., Grimes M., Mahoney E.R. Attention deficit/hyperactivity disorder (ADHD) symptoms and digit ratios in a college sample. Am. J. Hum. Biol. 2007, 19:41-50. 10.1002/ajhb.20571.
216. Strous R.D., Spivak B., Yoran-Hegesh R., Maayan R., Averbuch E., Kotler M., Mester R., Weizman A. Analysis of neurosteroid levels in attention deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. 2001, 4:259-264. 10.1017/S1461145701002462.
217. Suto J. Genetic dissection of testis weight in mice: quantitative trait locus analysis using F(2) intercrosses between strains with extreme testis weight, and association study using Y-consomic strains. Mamm. Genome 2011, 22:648-660. 10.1007/s00335-011-9353-3.
218. Tartaglia N.R., Ayari N., Hutaff-Lee C., Boada R. Attention-deficit hyperactivity disorder symptoms in children and adolescents with sex chromosome aneuploidy: XXY, XXX, XYY, and XXYY. J. Dev. Behav. Pediatr. 2012, 33:309-318. 10.1097/DBP.0b013e31824501c8.
219. Taurines R., Schmitt J., Renner T., Conner A.C., Warnke A., Romanos M. Developmental comorbidity in attention-deficit/hyperactivity disorder. Atten. Defic. Hyperact. Disord. 2010, 2:267-289. 10.1007/s12402-010-0040-0.
220. Thapar A., O'Donovan M., Owen M.J. The genetics of attention deficit hyperactivity disorder. Hum. Mol. Genet. 2005, 14:R275-R282. 10.1093/hmg/ddi263.
221. Thapar A., Cooper M., Jefferies R., Stergiakouli E. What causes attention deficit hyperactivity disorder?. Arch. Dis. Child. 2012, 97:260-265. 10.1136/archdischild-2011-300482.
222. Thapar A., Cooper M., Eyre O., Langley K. What have we learnt about the causes of ADHD?. J. Child Psychol. Psychiatry 2013, 54:3-16. 10.1111/j.1469-7610.2012.02611.x.
223. Tobias E.S., Bryce G., Farmer G., Barton J., Colgan J., Morrison N., Cooke A., Tolmie J.L. Absence of learning difficulties in a hyperactive boy with a terminal Xp deletion encompassing the MRX49 locus. J. Med. Genet. 2001, 38:466-470.
224. Tomasi D., Volkow N.D. Abnormal functional connectivity in children with attention-deficit/hyperactivity disorder. Biol. Psychiatry 2012, 71:443-450. 10.1016/j.biopsych.2011.11.003.
225. Trent S., Davies W. The influence of sex-linked genetic mechanisms on attention and impulsivity. Biol. Psychol. 2012, 89:1-13. 10.1016/j.biopsycho.2011.09.011.
226. Trent S., Cassano T., Bedse G., Ojarikre O.A., Humby T., Davies W. Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice. Neuropsychopharmacology 2012, 37:1267-1274. 10.1038/npp.2011.314.
227. Trent S., Dennehy A., Richardson H., Ojarikre O.A., Burgoyne P.S., Humby T., Davies W. Steroid sulfatase-deficient mice exhibit endophenotypes relevant to attention deficit hyperactivity disorder. Psychoneuroendocrinology 2012, 37:221-229. 10.1016/j.psyneuen.2011.06.006.
228. Trent S., Dean R., Veit B., Cassano T., Bedse G., Ojarikre O.A., Humby T., Davies W. Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder. Psychoneuroendocrinology 2013, 38:1370-1380. 10.1016/j.psyneuen.2012.12.002.
229. Trent S., Fry J.P., Ojarikre O.A., Davies W. Altered brain gene expression but not steroid biochemistry in a genetic mouse model of neurodevelopmental disorder. Mol. Autism. 2014, 5:21. 10.1186/2040-2392-5-21.
230. Ullebo A.K., Posserud M.B., Heiervang E., Obel C., Gillberg C. Prevalence of the ADHD phenotype in 7- to 9-year-old children: effects of informant, gender and non-participation. Soc. Psychiatry Psychiatry Epidemiol. 2012, 47:763-769. 10.1007/s00127-011-0379-3.
231. Valera E.M., Brown A., Biederman J., Faraone S.V., Makris N., Monuteaux M.C., Whitfield-Gabrieli S., Vitulano M., Schiller M., Seidman L.J. Sex differences in the functional neuroanatomy of working memory in adults with ADHD. Am. J. Psychiatry 2010, 167:86-94. 10.1176/appi.ajp.2009.09020249.
232. van Ewijk H., Heslenfeld D.J., Zwiers M.P., Buitelaar J.K., Oosterlaan J. Diffusion tensor imaging in attention deficit/hyperactivity disorder: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2012, 36:1093-1106. 10.1016/j.neubiorev.2012.01.003.
233. Volavka J., Bilder R., Nolan K. Catecholamines and aggression: the role of COMT and MAO polymorphisms. Ann. N. Y. Acad. Sci. 2004, 1036:393-398. 10.1196/annals.1330.023.
234. Waddell J., McCarthy M.M. Sexual differentiation of the brain and ADHD: what is a sex difference in prevalence telling Us?. Curr. Top. Behav. Neurosci. 2012, 9:341-360. 10.1007/7854_2010_114.
235. Wang L.J., Hsiao C.C., Huang Y.S., Chiang Y.L., Ree S.C., Chen Y.C., Wu Y.W., Wu C.C., Shang Z.Y., Chen C.K. Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate. Psychoneuroendocrinology 2011, 36:1209-1216. 10.1016/j.psyneuen.2011.02.014.
236. Wang L.J., Huang Y.S., Hsiao C.C., Chiang Y.L., Wu C.C., Shang Z.Y., Chen C.K. Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder. World J. Biol. Psychiatry 2011, 12:99-109. 10.3109/15622975.2010.512090.
237. Wehmeier P.M., Schacht A., Escobar R., Hervas A., Dickson R. Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials. Atten. Defic. Hyperact. Disord. 2012, 4:25-35. 10.1007/s12402-011-0070-2.
238. Weinberg J., Sliwowska J.H., Lan N., Hellemans K.G. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome. J. Neuroendocrinol. 2008, 20:470-488. 10.1111/j.1365-2826.2008.01669.x.
239. Wermter A.K., Kamp-Becker I., Strauch K., Schulte-Korne G., Remschmidt H. No evidence for involvement of genetic variants in the X-linked neuroligin genes NLGN3 and NLGN4X in probands with autism spectrum disorder on high functioning level. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:535-537. 10.1002/ajmg.b.30618.
240. Wilens T.E., Decker M.W. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem. Pharmacol. 2007, 74:1212-1223. 10.1016/j.bcp.2007.07.002.
241. Wilhelm D., Koopman P. The makings of maleness: towards an integrated view of male sexual development. Nat. Rev. Genet. 2006, 7:620-631. 10.1038/nrg1903.
242. Wilkening S., Chen B., Bermejo J.L., Canzian F. Is there still a need for candidate gene approaches in the era of genome-wide association studies?. Genomics 2009, 93:415-419. 10.1016/j.ygeno.2008.12.011.
243. Wilkinson L.S., Davies W., Isles A.R. Genomic imprinting effects on brain development and function. Nat. Rev. Neurosci. 2007, 8:832-843. 10.1038/nrn2235.
244. Willcutt E.G. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012, 9:490-499. 10.1007/s13311-012-0135-8.
245. Williams N.M., Franke B., Mick E., Anney R.J., Freitag C.M., Gill M., et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3. Am. J. Psychiatry 2012, 169:195-204.
246. Wise A.L., Gyi L., Manolio T.A. EXclusion: toward integrating the X chromosome in genome-wide association analyses. Am. J. Hum. Genet. 2013, 92:643-647. 10.1016/j.ajhg.2013.03.017.
247. Wodka E.L., Mostofsky S.H., Prahme C., Gidley Larson J.C., Loftis C., Denckla M.B., Mahone E.M. Process examination of executive function in ADHD: sex and subtype effects. Clin. Neuropsychol. 2008, 22:826-841. 10.1080/13854040701563583.
248. Wolstenholme J.T., Rissman E.F., Bekiranov S. Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes. Genes Brain Behav. 2013, 12:166-180. 10.1111/gbb.12010.
249. Woo B.S., Rey J.M. The validity of the DSM-IV subtypes of attention-deficit/hyperactivity disorder. Aust. N. Z. J. Psychiatry 2005, 39:344-353. 10.1111/j.1440-1614.2005.01580.x.
250. Wu J.B., Chen K., Li Y., Lau Y.F., Shih J.C. Regulation of monoamine oxidase A by the SRY gene on the Y chromosome. FASEB J. 2009, 23:4029-4038. 10.1096/fj.09-139097.
251. Wu J., Xiao H., Sun H., Zou L., Zhu L.Q. Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol. Neurobiol. 2012, 45:605-620. 10.1007/s12035-012-8278-5.
252. Xia S., Li X., Kimball A.E., Kelly M.S., Lesser I., Branch C. Thalamic shape and connectivity abnormalities in children with attention-deficit/hyperactivity disorder. Psychiatry Res. 2012, 204:161-167. 10.1016/j.pscychresns.2012.04.011.
253. Xu X., Brookes K., Sun B., Ilott N., Asherson P. Investigation of the serotonin 2C receptor gene in attention deficit hyperactivity disorder in UK samples. BMC Res. Notes 2009, 2:71. 10.1186/1756-0500-2-71.
254. Yan J., Feng J., Schroer R., Li W., Skinner C., Schwartz C.E., Cook E.H., Sommer S.S. Analysis of the neuroligin 4Y gene in patients with autism. Psychiatry Genet. 2008, 18:204-207. 10.1097/YPG.0b013e3282fb7fe6.
255. Yen P.H., Marsh B., Allen E., Tsai S.P., Ellison J., Connolly L., Neiswanger K., Shapiro L.J. The human X-linked steroid sulfatase gene and a Y-encoded pseudogene: evidence for an inversion of the Y chromosome during primate evolution. Cell 1988, 55:1123-1135.
256. Zang Y.F., He Y., Zhu C.Z., Cao Q.J., Sui M.Q., Liang M., Tian L.X., Jiang T.Z., Wang Y.F. Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain Dev. 2007, 29:83-91. 10.1016/j.braindev.2006.07.002.
257. Zechner U., Wilda M., Kehrer-Sawatzki H., Vogel W., Fundele R., Hameister H. A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution?. Trends Genet. 2001, 17:697-701.
258. Zhang Y., Morales A.C., Jiang M., Zhu Y., Hu L., Urrutia A.O., Kong X., Hurst L.D. Genes that escape X-inactivation in humans have high intraspecific variability in expression, are associated with mental impairment but are not slow evolving. Mol. Biol. Evol. 2013, 10.1093/molbev/mst148.
259. Zheng Z., Cohn M.J. Developmental basis of sexually dimorphic digit ratios. Proc. Natl. Acad. Sci. USA 2011, 108:16289-16294. 10.1073/pnas.1108312108.
260. Zhong Q., Layman L.C. Genetic considerations in the patient with Turner syndrome-45, X with or without mosaicism. Fertil. Steril. 2012, 98:775-779. 10.1016/j.fertnstert.2012.08.021.
261. Zhu C.Z., Zang Y.F., Cao Q.J., Yan C.G., He Y., Jiang T.Z., Sui M.Q., Wang Y.F. Fisher discriminative analysis of resting-state brain function for attention-deficit/hyperactivity disorder. Neuroimage 2008, 40:110-120. 10.1016/j.neuroimage.2007.11.029.
262. Zinn A.R., Roeltgen D., Stefanatos G., Ramos P., Elder F.F., Kushner H., Kowal K., Ross J.L. A Turner syndrome neurocognitive phenotype maps to Xp22.3. Behav. Brain Funct. 2007, 3:24. 10.1186/1744-9081-3-24.